Profilo
Glen C.
MacDonald is currently the President, CEO, CFO & Director at Leucadia Finance Partners, Inc. He was previously the Chief Scientific Officer at Viventia Biotech, Inc. from 2005 to 2012 and again from 2012 to 2016.
He was also the Chief Scientific Officer at Sesen Bio, Inc. from 2016 to 2017.
Additionally, he held a position as Principal at Princess Margaret Hospital Foundation and The University of North Carolina at Charlotte.
Dr. MacDonald received his undergraduate degree from the University of Guelph in 1980, his graduate degree from the University of Manitoba in 1987, and his doctorate from the University of Manitoba in 1993.
Posizioni attive di Glen MacDonald
| Società | Posizione | Inizio |
|---|---|---|
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Amministratore Delegato | - |
Precedenti posizioni note di Glen MacDonald
| Società | Posizione | Fine |
|---|---|---|
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Direttore Tecnico/Scientifico/R&S | 01/09/2016 |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
| CARISMA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Princess Margaret Hospital Foundation | Corporate Officer/Principal | - |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di Glen MacDonald
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princess Margaret Hospital Foundation | |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Health Technology |
















